What’s the Deal? Canadian Biotech VC’s and How They’re Navigating COVID-19
While a lot is unknown right now with COVID-19, the effects of the disease are being seen globally, especially in the economy and the state of the markets. How is venture capital handling the pandemic, and what impact could the crisis have on startup investment activity?
In this program, biotech VC’s from across Canada will comment on the investment landscape and discuss:
- How they’re reacting to the outbreak
- How they feel the investment landscape changed?
- What they think this mean for investments and startups?
- What investors are doing according to them – assessing opportunities, closing funds, etc.
- Their current expectations for investments
- Words of wisdom for startups during this time
The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.